CXCR4 signaling identifies a role for IFT2 in ER-negative breast cancers

Jonathan R. Brody, Agnieszka K. Witkiewicz

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)615-616
Number of pages2
JournalCancer Biology and Therapy
Volume10
Issue number6
DOIs
StatePublished - Sep 15 2010

Keywords

  • Breast cancer
  • CXCR4
  • ER-negative
  • Heterogeneity
  • ITF2
  • MDA-MB-231 cells
  • Microarray

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this